Status:
COMPLETED
A Study of the Efficacy and Safety of Varenicline in Japanese Smokers Motivated to Quit Smoking
Lead Sponsor:
Pfizer
Conditions:
Smoking
Eligibility:
All Genders
20-75 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to evaluate the efficacy and safety of varenicline in Japanese smokers. Efficacy is evaluated by continuous quit rate and withdrawal symptoms of smokers. Safety is evaluat...
Eligibility Criteria
Inclusion
- Japanese smokers motivated to quit smoking
- No period without smoking of more than 3 months
- Smoked an average of at least 10 cigarettes/day in the past year
Exclusion
- Subjects who have used nicotine replacement therapy within 1 month of the study screening visit
- Subjects intending to use nicotine replacement therapy or other smoking cessation treatments during the study
Key Trial Info
Start Date :
May 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2004
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00635401
Start Date
May 1 2004
End Date
August 1 2004
Last Update
April 10 2008
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Chuo-ku Fukuoka, Fukuoka, Japan
2
Pfizer Investigational Site
Nishi-ku Yokohama, Kanagawa, Japan
3
Pfizer Investigational Site
Beppu, Oita Prefecture, Japan
4
Pfizer Investigational Site
Ōita, Oita Prefecture, Japan